C07D 249/06
With aryl radicals directly attached to ring atoms
Official title: with aryl radicals directly attached to ring atoms
C07D249/06 (With aryl radicals directly attached to ring atoms) appears on 554 US grants and 652 published applications in this corpus.
Search patents in C07D- Granted patents
- 554
- Published applications
- 652
- Assignees
- 397
- Inventors
- 2,401
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 12 | 0 |
| 1978 | 5 | 0 |
| 1979 | 4 | 0 |
| 1980 | 6 | 0 |
| 1981 | 8 | 0 |
| 1982 | 5 | 0 |
| 1983 | 3 | 0 |
| 1984 | 4 | 0 |
| 1985 | 3 | 0 |
| 1986 | 7 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 6 | 0 |
| 2001 | 9 | 1 |
| 2002 | 11 | 3 |
| 2003 | 6 | 14 |
| 2004 | 4 | 16 |
| 2005 | 8 | 19 |
| 2006 | 10 | 18 |
| 2007 | 6 | 21 |
| 2008 | 8 | 16 |
| 2009 | 8 | 23 |
| 2010 | 22 | 31 |
| 2011 | 22 | 27 |
| 2012 | 20 | 31 |
| 2013 | 24 | 28 |
| 2014 | 30 | 28 |
| 2015 | 24 | 38 |
| 2016 | 29 | 35 |
| 2017 | 19 | 33 |
| 2018 | 32 | 30 |
| 2019 | 22 | 26 |
| 2020 | 23 | 28 |
| 2021 | 26 | 38 |
| 2022 | 18 | 35 |
| 2023 | 23 | 39 |
| 2024 | 18 | 30 |
| 2025 | 20 | 26 |
| 2026 | 16 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Composition for prevention or treatment of neurofibromatosis type 2 syndrome22 Sep 2026US 12,741,946 B2Prg S&Tech Inc.
- 18F-labeled triazole containing PSMA inhibitors14 Jul 2026US 12,679,812 B2Cornell University
- Valiolamine derivatives as glucosidase inhibitors7 Jul 2026US 12,673,924 B2Emergent Product Development Gaithersburg Inc.
- Biphenyl compounds as SOCE modulators, compositions and uses thereof16 Jun 2026US 12,655,113 B2Universita Degli Studi Del Piemonte Orientale "Amedeo Avogadro"
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Synthetic methods of making (2h-1, 2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators1 Oct 2026US 2026/0297096 A1Janssen Pharmaceutica NV
- Inhibitors of myc and uses thereof17 Sep 2026US 2026/0274827 A1Northwestern University
- N,N-dialkyl-4-(2-ethylindan-2-yl)-1H-imidazole-1-carboxamides and related compounds for treatment of neurodegenerative diseases2 Jul 2026US 2026/0183273 A1Univerza v Ljubljani
- Compounds as modulators of stat6 and uses thereof18 Jun 2026US 2026/0166047 A1Amgen Inc.
Most cited
By later US patents
- Copper-catalysed ligation of azides and acetylenes267US 7,375,234 B2The Scripps Research Institute · 2008
- Nitrogen containing heteroaromatics as factor Xa inhibitors211US 6,020,357 ADuPont Pharmaceuticals Company · 2000
- Medicaments for the treatment of disorders of lipometabolism and their use138US 4,405,644 ABayer Aktiengesellschaft · 1983
- 7-pyrrolyl tetracycline compounds and methods of use thereof73US 7,001,918 B2Paratek Pharmaceuticals, Inc. · 2006
- Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.71US 7,049,306 B2Elan Pharmaceuticals, Inc. · 2006